hCG Priming in Women With Diminished Ovarian Reserve

PHASE3RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

March 31, 2028

Study Completion Date

March 31, 2031

Conditions
Infertility, FemaleOvarian ReserveIn Vitro Fertilization (IVF)
Interventions
DRUG

Choriongonadotropin alfa (hCG)

hCG 260 IU once daily for two menstrual cycles (aproximately 8 weeks) prior til standard IVF/ICSI.

DRUG

Isotonic NaCl (Placebo)

Placebo priming (isotone NaCl) once daily for two menstrual cycles (approximately 8 weeks) prior to standard IVF/ICSI.

Trial Locations (1)

2100

RECRUITING

Fertility Clinic, Department of Gynaecology, Fertility and Obstetrics, Copenhagen University Hosital Rigshospitalet, Copenhagen

All Listed Sponsors
collaborator

Copenhagen University Hospital, Hvidovre

OTHER

collaborator

Copenhagen University Hospital at Herlev

OTHER

collaborator

Odense University Hospital

OTHER

lead

Kristine Loessl

OTHER

NCT07108621 - hCG Priming in Women With Diminished Ovarian Reserve | Biotech Hunter | Biotech Hunter